These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 2392158)
1. Reduction of BM 15.766-induced 7-dehydrocholesterol accumulation by bezafibrate and mevinolin in rats. A non-isotopic in vivo test system for compounds reducing cholesterol synthesis. Pill J; Witte EC; Schmidt FH Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):552-6. PubMed ID: 2392158 [TBL] [Abstract][Full Text] [Related]
2. Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis. Pill J; Stegmeier K; Schmidt FH Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):167-74. PubMed ID: 2352446 [TBL] [Abstract][Full Text] [Related]
3. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations. Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416 [TBL] [Abstract][Full Text] [Related]
4. The effects of BM 15.766, an inhibitor of 7-dehydrocholesterol delta 7-reductase, on cholesterol biosynthesis in primary rat hepatocytes. Aufenanger J; Pill J; Schmidt FH; Stegmeier K Biochem Pharmacol; 1986 Mar; 35(6):911-6. PubMed ID: 3754141 [TBL] [Abstract][Full Text] [Related]
5. [Elevation of 7-dehydrocholesterol concentrations in serum and liver and pericentral peroxisome proliferation in hepatocytes of rats after inhibition of cholesterol biosynthesis by BM 15,766]. Weiss MC; Baumgart E; Fahimi HD; Pill H; Rebel W; Hartig F Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):66-9. PubMed ID: 7786281 [TBL] [Abstract][Full Text] [Related]
6. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities. Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931 [TBL] [Abstract][Full Text] [Related]
7. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766. Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099 [TBL] [Abstract][Full Text] [Related]
8. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats. Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648 [TBL] [Abstract][Full Text] [Related]
9. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats. Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417 [TBL] [Abstract][Full Text] [Related]
10. Dichlorophenyl piperazines, including a recently-approved atypical antipsychotic, are potent inhibitors of DHCR7, the last enzyme in cholesterol biosynthesis. Genaro-Mattos TC; Tallman KA; Allen LB; Anderson A; Mirnics K; Korade Z; Porter NA Toxicol Appl Pharmacol; 2018 Jun; 349():21-28. PubMed ID: 29698737 [TBL] [Abstract][Full Text] [Related]
11. The increase in skin 7-dehydrocholesterol induced by an hypocholesterolemic agent is associated with elevated 25-hydroxyvitamin D3 plasma level. Bonjour JP; Trechsel U; Granzer E; Klöpffer G; Müller K; Scholler D Pflugers Arch; 1987 Sep; 410(1-2):165-8. PubMed ID: 2825113 [TBL] [Abstract][Full Text] [Related]
12. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase. Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381 [TBL] [Abstract][Full Text] [Related]
13. [Pharmacological investigation of bezafibrate, a hypolipidemic agent (2). Mechanism of the hypolipidemic action of bezafibrate in rats]. Kusama H; Nishiyama M; Matsubara Y; Ikeda S Nihon Yakurigaku Zasshi; 1988 Sep; 92(3):181-91. PubMed ID: 2907502 [TBL] [Abstract][Full Text] [Related]
14. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome. Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321 [TBL] [Abstract][Full Text] [Related]
17. Influence of simvastatin, pravastatin, and BM 15.766 on neutral sterols in liver and testis of guinea pigs. Lindenthal B; Bertsch T; Fassbender K; Stroick M; Kühl S; Lütjohann D; von Bergmann K Metabolism; 2002 Apr; 51(4):492-9. PubMed ID: 11912560 [TBL] [Abstract][Full Text] [Related]
18. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis. Alberts AW Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667 [TBL] [Abstract][Full Text] [Related]
19. 7-Dehydrocholesterol metabolites produced by sterol 27-hydroxylase (CYP27A1) modulate liver X receptor activity. Endo-Umeda K; Yasuda K; Sugita K; Honda A; Ohta M; Ishikawa M; Hashimoto Y; Sakaki T; Makishima M J Steroid Biochem Mol Biol; 2014 Mar; 140():7-16. PubMed ID: 24269243 [TBL] [Abstract][Full Text] [Related]
20. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats. Maxwell RE; Nawrocki JW; Uhlendorf PD Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]